A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants

Summary

The purpose of this study is to evaluate safety, tolerability, immunogenicity, pharmacokinetics, pharmacodynamics, and efficacy of LP-003 in healthy volunteers. The study will be conducted in 2 parts: Part 1, the single ascending dose (SAD) is the first in human (FIH) study of LP-003 and Part 2, multiple ascending dose (MAD).

Timeline

Start

2022-07-13

Primary completion

2024-03-04

Completion

2024-03-04

Drugs

Indications